Application 074292

Type: ANDA
Sponsor: HOSPIRA

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	DOBUTAMINE HYDROCHLORIDE	DOBUTAMINE HYDROCHLORIDE	INJECTABLE;INJECTION	EQ 12.5MG BASE/ML	No	Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A074292-001	DOBUTAMINE HYDROCHLORIDE	DOBUTAMINE HYDROCHLORIDE	EQ 12.5MG BASE/ML	INJECTABLE / INJECTION			1995-02-16

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 2 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2022-09-29 23:25 UTC	2022-09	A074292-001	DOBUTAMINE HYDROCHLORIDE	EQ 12.5MG BASE/ML	INJECTABLE / INJECTION	1995-02-16	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A074292-001	DOBUTAMINE HYDROCHLORIDE	EQ 12.5MG BASE/ML	INJECTABLE / INJECTION	1995-02-16	`cb3db0bc1861…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A074292-001	DOBUTAMINE HYDROCHLORIDE	EQ 12.5MG BASE/ML	INJECTABLE / INJECTION	1995-02-16	`a50c72e98297…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-12-13 00:20 UTC	2019-12	A074292-001	AP	1	`74a2ff9319b5…`
2019-12-14 00:12 UTC	2019-12	A074292-001	AP	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A074292-001	AP	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A074292-001	AP	1	`ea99ee380514…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
DOBUTAMINE HYDROCHLORIDE	DOBUTAMINE HYDROCHLORIDE	HF Acquisition Co LLC, DBA HealthFirst	c6ceb8d3-e46e-f0da-e053-2995a90a8c3c	2024-01-30	Warnings, Adverse reactions	Name fallback brand name: DOBUTAMINE HYDROCHLORIDE generic name: DOBUTAMINE HYDROCHLORIDE
Dobutamine Hydrochloride in Dextrose	DOBUTAMINE HYDROCHLORIDE	Baxter Healthcare Corporation	6b17b98b-e06d-42ed-925f-69aa2699dead	2023-09-08	Warnings, Adverse reactions	Name fallback generic name: DOBUTAMINE HYDROCHLORIDE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 4 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
0409-2025	DOBUTAMINE	DOBUTAMINE	Hospira, Inc.	ANDA	Current
0409-2025	DOBUTAMINE	DOBUTAMINE	Hospira, Inc.	ANDA	Current
0409-2025	DOBUTAMINE	DOBUTAMINE	Hospira, Inc.	ANDA	Current
52584-048	Dobutamine	Dobutamine Hydrochloride Injection	General Injectables and Vaccines, Inc.	ANDA	Current